[Expression level of miRNA-663 in different leukemic cell lines and its biological function]

Area of Science:

• Molecular Biology
• Cancer Research
• Epigenetics

Context:

• MicroRNAs (miRNAs) play crucial roles in gene regulation and are implicated in various diseases, including cancer.
• Chronic Myeloid Leukemia (CML) is a hematological malignancy characterized by specific genetic mutations and altered gene expression.
• Epigenetic modifications, such as DNA methylation, can silence tumor suppressor genes and contribute to cancer development.

Purpose:

• To identify microRNAs (miRNAs) upregulated in K562 cells upon treatment with 5-aza (a hypomethylating agent).
• To compare miRNA expression levels in healthy individuals, CML patients, and leukemia cell lines.
• To investigate the functional impact of miRNA on K562 cell proliferation and the epigenetic regulation of miR-663.

Summary:

• Microarray and bioinformatics analysis identified miR-638, miR-663, and miR-92b as upregulated in 5-aza-treated K562 cells, with miR-663 further confirmed by real-time PCR.
• Expression analysis revealed lower levels of miR-663 in K562, U937, and Kasumi cell lines, as well as in newly diagnosed CML patients, compared to healthy individuals.
• Methylation-specific PCR indicated that the CpG island of miR-663 is methylated in K562 cells. Overexpression of miR-663 in vitro suppressed K562 cell proliferation.

Impact:

• The findings suggest that miR-663 is epigenetically silenced via CpG island methylation in leukemia cells.
• Downregulation of miR-663 in leukemia patients and cell lines indicates its potential role as a tumor suppressor.
• Restoration of miR-663 expression, potentially through hypomethylating agents, may offer a novel therapeutic strategy for leukemia by inhibiting cancer cell proliferation.